Methocarbamol Oral |
Robaxin |
Article: Methocarbamol
| Image:Methocarbamol.png | |
| Methocarbamol | |
| Systematic (IUPAC) name | |
| [2-hydroxy-3-(2-methoxyphenoxy)-propyl] aminoformate | |
| Identifiers | |
| CAS number | 532-03-6 |
| ATC code | M03BA03 |
| PubChem | 4107 |
| DrugBank | APRD01102 |
| Chemical data | |
| Formula | C11H15NO5 |
| Mol. weight | 241.241 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | 1.14-1.24 hours[1] |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | Oral, intravenous |
Methocarbamol (chemical formula: ) is a central muscle relaxant for skeletal muscles, used to treat spasms. Robaxin, Robaxacet, and Robax Platinum are trade names for methocarbamol. It is structurally related to guaifenesin.
Resources
- Methocarbamol Oral (Drug Digest)
- Robaxin (Drug Digest)

Not Signed In -


